NORDIX DNA ApS: Financial statements 2023
CVR: 36908130
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
NORDIX DNA ApS (CVR 36908130) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 689,536 and a net result of DKK 7,578 compared with DKK 74,000 the year before. That is a decrease of 8.7% compared with the year before. Equity in the 2023 report amounted to DKK 106,345. The solvency ratio was 15.9%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 689,536
- Profit/Loss
- DKK 7,578
- Equity
- DKK 106,345
- Total Assets
- DKK 669,179
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 690 t. | 8 t. | 106 t. | 2 |
| 2022 | - | 755 t. | 74 t. | 114 t. | 2 |
| 2021 | - | 218 t. | 14 t. | 40 t. | 1 |
| 2020 | - | -4 t. | -7 t. | -14 t. | 1 |
| 2019 | - | -1 t. | -1 t. | -7 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
NORDIX DNA ApS has published its annual report for 2022. Gross profit came to DKK 755,244, and the net result was DKK 74,000.
About NORDIX DNA ApS
NORDIX DNA ApS is a Danish company of the type Anpartsselskab based in Frederikshavn, founded in 2015. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named NORDIX DNA IVS and FAB.DK IVS. The management consists of Casper Holm Mulberg. The company is owned by NORDIX HOLDING ApS. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -9,011 and a net result of DKK -9,011 compared with DKK -98,799 the year before. Equity in the 2025 report amounted to DKK -1,465.